Aim: To assess the haemostatic efficacy of the self-expanding metal stent (SEMS) in the patients with severe esophageal variceal (EV) bleeding and endoscopic treatment failure. Material and methods: A total of 12 patients M(n = 8), with the mean ± SD age—46.92 ± 3.09 (24–62 years) with liver cirrhosis and bleeding EV (n = 8), esophageal postbanding ulcers (n = 4) were included in the study. The main selection criterion was endoscopic treatment failure. A removable covered SEMS (SX-ELLA stent Danis, 135 9 25 mm, ELLA-CS, Hradec-Kralove, Czech Republic) was used in all cases.Themean ± SDSEMSrequired per patientwas 1.25 ± 0.18 (1-3). All definitions were used according to Baveno Consensus (I-V). Results: Initial hemostasis was achieved in all cases. Partial distal stent migration rate, documented on X-ray and CT- scan, was 5/12 (41.6%) and stent reposition was achieved by second-look endoscopy. The 30-days death rate was 3/12 (25%) due to hepatic failure in 2/12 (16.66%) and bleeding EV distally to the stent distal end 1/12 (8.34%). Conclusions: The preliminary results prove that SEMS are effective in high-risk patients with severe esophageal variceal hemorrhage and endoscopic hemostasis failure as well as postbanding esophageal ulcers. Final conclusions will be reached after gaining experience with this new method on larger patient series.